Long-term cardiovascular burden in prostate cancer patients receiving androgen deprivation therapy

Eur J Clin Invest. 2023 Apr;53(4):e13932. doi: 10.1111/eci.13932. Epub 2022 Dec 12.
No abstract available

Keywords: androgen deprivation therapy; cardio-oncology; epidemiology; prostate cancer.

Publication types

  • Letter

MeSH terms

  • Androgen Antagonists / therapeutic use
  • Androgens / therapeutic use
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Cardiovascular System*
  • Heart
  • Humans
  • Male
  • Prostatic Neoplasms*

Substances

  • Androgen Antagonists
  • Androgens
  • Antineoplastic Agents, Hormonal